(19)
(11) EP 4 798 597 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 25700611.4

(22) Date of filing: 07.01.2025
(51) International Patent Classification (IPC): 
C07H 19/00(2006.01)
C12Q 1/6869(2018.01)
C07H 21/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07H 19/00; C07H 21/00; C12Q 1/6869; C07H 19/06
 
C-Sets:
C12Q 1/6869, C12Q 2525/113, C12Q 2525/117, C12Q 2565/631;
(86) International application number:
PCT/EP2025/050239
(87) International publication number:
WO 2025/149478 (17.07.2025 Gazette 2025/29)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 12.01.2024 US 202463620346 P

(71) Applicant: Roche Sequencing Solutions, Inc.
Pleasanton, CA 94588 (US)

(72) Inventors:
  • GOODMAN, Drew
    Pleasanton, California 94588 (US)
  • JACOBS, Aaron
    Pleasanton, California 94588 (US)
  • KOKORIS, Mark Stamatios
    Pleasanton, California 94588 (US)
  • LEHMANN, Taylor
    Pleasanton, California 94588 (US)
  • LOPEZ, Matthew
    Pleasanton, California 94588 (US)
  • NABAVI, Melud
    Pleasanton, California 94588 (US)
  • O´CONNELL, Dylan
    Pleasanton, California 94588 (US)
  • TABONE, John C.
    Pleasanton, California 94588 (US)

(74) Representative: Mockenhaupt, Stefan 
Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg
82377 Penzberg (DE)

   


(54) COMPOSITIONS OF MODIFIED NUCLEOSIDE TRIPHOSPHATES